NDC 69238-1471 – Erythromycin
Erythromycin 250 mg/1 · Tablet, Delayed Release · Oral
Product NDC69238-1471
Product details
- Brand name
- Erythromycin
- Generic name
- Erythromycin
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- Tablet, Delayed Release
- Route
- Oral
- Marketing category
- ANDA · ANDA210954
- Marketed since
- July 7, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Macrolide Antimicrobial; Macrolide
Active ingredients
- Erythromycin 250 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 69238-1471-1 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1471-1) | Jul 7, 2019 |
| 69238-1471-3 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1471-3) | Aug 27, 2021 |
Other Erythromycin products
- 69238-1473 Erythromycin 500 mg/1 · Tablet, Delayed Release · Amneal Pharmaceuticals NY LLC
- 69238-1472 Erythromycin 333 mg/1 · Tablet, Delayed Release · Amneal Pharmaceuticals NY LLC
- 51407-853 Erythromycin 250 mg/1 · Tablet, Delayed Release · Golden State Medical Supply, Inc.
- 51407-854 Erythromycin 500 mg/1 · Tablet, Delayed Release · Golden State Medical Supply, Inc.
- 13668-586 Erythromycin 250 mg/1 · Tablet, Delayed Release · Torrent Pharmaceuticals Limited
- 13668-587 Erythromycin 333 mg/1 · Tablet, Delayed Release · Torrent Pharmaceuticals Limited
- 13668-588 Erythromycin 500 mg/1 · Tablet, Delayed Release · Torrent Pharmaceuticals Limited
- 52536-180 Erythromycin 250 mg/1 · Tablet, Delayed Release · Wilshire Pharmaceuticals
- 52536-186 Erythromycin 500 mg/1 · Tablet, Delayed Release · Wilshire Pharmaceuticals
- 52536-183 Erythromycin 333 mg/1 · Tablet, Delayed Release · Wilshire Pharmaceuticals
- 50090-1484 Erythromycin 5 mg/g · Ointment · A-S Medication Solutions
- 50090-5918 Erythromycin 250 mg/1 · Tablet, Film Coated · A-S Medication Solutions